ARTICLE | Clinical News
Ameluz aminolevulinic acid regulatory update
September 26, 2016 7:00 AM UTC
The European Commission approved a label expansion for Biofrontera’s Ameluz aminolevulinic acid to include treatment of actinic keratosis of field cancerization. Field cancerization refers to a field ...